AI Agent Operational Lift for Surestep in South Bend, Indiana

Why AI matters at this scale

Surestep operates in a unique niche—pediatric orthotics—where precision and personalization directly impact a child's development. As a mid-market manufacturer (201–500 employees) with an estimated $75M in revenue, the company sits at a critical inflection point. It is large enough to have accumulated a valuable proprietary dataset from thousands of fittings, yet lean enough to adopt AI without the bureaucratic inertia of a mega-corporation. The medical device sector is increasingly embracing AI for design, diagnostics, and personalization, and Surestep's focused product line makes it an ideal candidate for targeted, high-ROI AI initiatives.

1. AI-Powered Gait Analysis and Design Automation

The highest-impact opportunity lies in automating the clinical assessment process. Currently, orthotists rely on manual video review and experience to select and modify orthotics. By training a computer vision model on Surestep's extensive video library of pediatric gait patterns, the company can offer a tool that automatically detects pronation, supination, and other deviations, then maps them to the optimal Surestep product configuration. This reduces clinician time per fitting, lowers the risk of suboptimal prescriptions, and strengthens Surestep's value proposition as a technology partner, not just a manufacturer. The ROI is twofold: increased sales velocity through faster clinical decisions and reduced remake costs from better first-time fits.

2. Predictive Inventory and Supply Chain Optimization

Custom orthotics involve numerous SKUs, from shell sizes to strap colors and densities. Demand fluctuates with referral patterns, seasonal changes, and new clinician onboarding. Applying time-series forecasting models to historical order data can predict component demand with high accuracy. This allows Surestep to shift from reactive manufacturing to a just-in-time model, cutting raw material waste and warehousing costs. For a company of this size, a 15% reduction in inventory carrying costs could free up significant working capital for R&D.

3. Clinician Copilot for Enhanced Support

Surestep provides extensive clinical support to orthotists fitting their products. An internal LLM-powered copilot, fine-tuned on Surestep's technical manuals, fitting guides, and anonymized case studies, can serve as a 24/7 expert assistant. This tool would handle routine questions, suggest troubleshooting steps, and even pre-fill insurance justification documentation. It preserves the specialized knowledge of Surestep's clinical team, reduces support ticket volume, and accelerates the onboarding of new clinician partners.

Deployment risks for a mid-market medical device firm

Implementing AI in a regulated environment requires careful governance. The primary risk is regulatory creep: if an AI tool influences clinical decisions, the FDA may classify it as Software as a Medical Device (SaMD), triggering a costly and lengthy clearance process. Surestep must initially position AI as a decision-support tool with a "human-in-the-loop" to mitigate this. Data privacy is another critical concern; patient video data must be de-identified and handled under HIPAA and GDPR-equivalent standards. Finally, as a mid-sized firm, Surestep risks over-investing in AI talent it cannot retain. A pragmatic approach using managed cloud AI services and a small, focused data science team, rather than building everything in-house, will balance ambition with financial sustainability.